3D 医疗和外科成像平台市场 - 增长、趋势、COVID-19 影响和预测（2022-2027 年）

在预测期内，3D 医疗和手术成像平台市场预计将以 18% 的复合年增长率增长。

此外，市场上平台提供商对医疗保健 IT 的各种创新解决方案和投资等某些因素正在推动 3D 医疗和手术成像平台市场。

主要亮点

• 由于其在心臟病学和肿瘤学中的广泛使用，3D 医学成像的需求量很大。例如，心臟瓣膜置换术是心脏病学中最常见的手术之一。经导管主动脉瓣置换术被认为是微创心臟瓣膜置换术之一。新心臟瓣膜的定位是外科医生非常关心的问题。外科医生更喜欢使用 3D 血管造影成像软件在放置新心臟瓣膜期间查看解剖结构，因为新心臟瓣膜的定位可能很关键。
• 此外，2021 年 5 月，英格兰国民健康服务 (NHS) 推出了一项名为“HeartFlow”的专有技术，用于快速检测和治疗疑似心脏病。根据 NHS 长期计划提供的 HeartFlow 据说可以将正常的心臟计算机断层扫描 (CT) 扫描转换为三维 (3D) 图像，从而能够在 20 分钟内检测出冠心病，并有望成为市场领先，进一步推动增长。
• 由于现代可视化技术和技术平台的快速发展，以及慢性病诊断和监测中对 3D 成像的需求不断增长，市场正在扩大。此外，向微创手术的转变和混合手术室的增加也推动了市场的发展。
• 此外，2021 年 12 月，WEHI（Walter and Eliza Hall Institute of Medical Research）的研究人员将开发一种新方法来模拟乳腺癌细胞如何侵入和扩散骨骼、重塑自身以促进肿瘤生长，并开发增强型 3D 成像技术。该研究可以指导为患有通常应用于骨骼的癌症（如乳腺癌和前列腺癌）的患者开发新的治疗方法。
• 创新图像处理技术的快速发展正在为研究目标市场的增长铺平道路。例如，2021 年 2 月，由 UMass Lowell 领导的一个研究小组宣布了一种新的 3D 成像技术，用于检测乳腺癌和其他疾病，包括 COVID-19。这种非侵入性医疗技术采用专门的对比增强染料来识别乳腺癌细胞，使从业者能够更好地观察体内的人体组织。这种染料与称为“光子计数光谱 CT”的计算机断层扫描 (CT) 扫描仪相结合，可放大肿瘤的 X 射线信号并产生多色 3D 图像。研究人员声称，将这种造影剂与光谱 CT 和机器学习相结合将导致更准确的疾病诊断，这将大大有助于早期干预。
• 此外，COVID-19 大流行直接和间接导致 2020 年和 2021 年上半年经合组织国家的死亡人数估计增加了 16%。30 个国家中的 24 个国家的预期寿命有所下降，大流行对心理健康产生了重大影响。大流行还导致经合组织的医疗保健支出大幅增加。

主要市场趋势

云有望实现显着增长

• 云计算为医学影像带来了原始数据管理的竞争优势。根据医疗影像解决方案的类型和行业发展水平，云计算将应用于云影像归檔、海量影像数据存储、远程医疗影像灾备、3D医疗影像应用、移动云影像等多种场景。还提供图像读取、图像中心等基于软件的应用程序。
• 企业成像系统和 PACS（图片存檔和通信系统）正在转向基于云的解决方案，因为它们可以解决各种医院问题。基于云的系统还有助于与大型医院电子病历 (EMR) 系统集成。
• 此外，医院和其他医疗机构可以通过利用基于云的解决方案最大限度地减少对 IT 基础设施的投资。这意味着可以通过自动化一些重复性的管理任务来降低劳动力成本。因此，云提供了很大的可扩展性，使医生能够专注于他们的病人，而不是他们的 IT 担忧。
• 此外，2021 年 8 月，GE Healthcare 宣布了其名为 Edison True PACS 的下一代基于云的图片存檔和通信系统 (PACS)。新的基于云的成像和工作流程解决方案支持面临越来越高的员工倦怠和退休率的放射科医生，使他们能够更准确、更高效地工作，同时控制资本和 IT 资源旨在此外，新解决方案为放射科医生提供了人工智能决策支持，以适应更高的工作量、增加检查的复杂性并提高诊断准确性。

北美预计将占据重要份额

• 由于手术数量的增加、慢性病患病率的增加以及该地区医院越来越多地采用混合手术室，预计北美将占据市场的重要份额。
• 该地区的 3D 成像研究和开发正在取得进展，自动化 3D 成像扫描仪的数量不断增加。例如，2022 年 7 月，SMARTTECH 扩展了其 3D 扫描仪配件系列。SMARTTECH 配件系列中新增的 Professional FOBA Stand 扩展了 SMARTTECH 3D 扫描仪的人体工程学使用可能性。
• 由于医院、长期护理中心和高度专业化中心等医疗环境的购买力不断增强，该地区的市场正在显着增长。此外，与发展中地区相比，有利的报销方案和完善的医疗基础设施预计将对预测期内该地区的增长产生积极影响。
• 医疗保健行业自动化程度的提高以及慢性病诊断和监测中对 3D 成像的需求不断增长等因素预计将丰富多家医疗保健公司进入该地区的机会。
• 此外，2022 年 1 月，Francisco Partners 将加入 IBM（美国）和 IBM 的投资组合公司，包括 Health Insights、MarketScan、Clinical Development、Social Program Management、Micromedex 和 Imaging Software Offerings，现在是 Watson Health 业务的一部分。开发医疗保健数据和分析资产的协议

竞争格局

由于少数主要参与者进入市场，3D 医疗和手术成像平台市场正在整合。市场参与者专注于研发，以开发技术先进的产品并降低与其产品相关的成本和副作用。该行业的参与者不断努力改进他们的产品组合，以通过併购、合作伙伴关係和不断创新来获得竞争优势。

• 2022 年 6 月——Trivitron Healthcare 计划在 2022-23 年推出印度製造的 CT 扫描和 MRI。由于其智能功能、低成本和便携性，它将在印度和国际市场上用于更好的诊断。它还将在印度孟买的 Patalganga 工业区开设第二家超声波製造工厂。
• 2021 年 11 月 - 健康技术的全球参与者ROYAL PHILIPS宣布在北美放射学会推出新的 AI 支持的 MR 成像创新。PHILIPS新的 MR 智能集成解决方案组合旨在帮助您加快 MR 检查、简化工作流程、优化诊断质量并确保放射学操作的效率和可持续性。

其他福利

• Excel 格式的市场预测 (ME) 表
• 3 个月的分析师支持

目录

第 1 章 简介

• 研究假设和市场定义
• 调查范围

第二章研究方法论

第三章执行摘要

第四章市场洞察

• 市场概况
• 行业吸引力——波特五力分析
  • 供应商的议价能力
  • 买方议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争对手之间的竞争
• 行业价值链分析
• COVID-19 的市场影响评估

第五章市场动态

• 市场驱动力
  • 慢性病诊断和监测中对 3D 成像的需求不断增长
  • 医疗保健支出增加
  • 开发最新的可视化方法和技术基础
• 市场挑战
  • 设备初始成本高

第六章市场细分

• 通过部署
  • 本地
  • 云
• 按组件
  • 硬件
  • 软件和解决方案
• 按申请
  • CT扫描
  • 核磁共振
  • 超声诊断
  • 神经影像学
  • 脊柱成像
  • 其他应用
• 区域信息
  • 北美
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第 7 章 竞争格局

• 公司简介
  • Ambra Health Inc.
  • Arterys Inc.
  • Brainlab AG
  • Depuy Synthes Inc.
  • Medtronic Inc.
  • Kitware Inc.
  • Mach7 Technologies Ltd
  • NDS Surgical Imaging LLC
  • Olympus Corporation
  • NerveVision Inc.
  • Siemens Healthcare Pvt. Ltd
  • Pie Medical Imaging BV
  • Quibim SI

第八章投资分析

第九章 市场潜力

The 3D Medical and Surgical Imaging Platform Market is expected to register a CAGR of 18% over the forecast period. Certain factors, such as the various inventive resolutions from platform providers in the market and investments in healthcare IT, are also liable for driving the 3D medical and surgical imaging platform market.

Key Highlights

• There is an increased demand for 3D medical imaging due to its vast applications in cardiology and oncology. For instance, Heart valve replacement is one of the most common procedures in cardiology. Transcatheter aortic valve replacement is considered one minimally invasive heart valve replacement procedure. Positioning the new heart valve is a severe concern to surgeons. Surgeons prefer 3D angiography imaging software to view the anatomy during the placement of heart valves, as positioning a new heart valve seems crucial.
• Additionally, in May 2021, the National Health Service England (NHS) unveiled a unique technology called HeartFlow to detect and treat people with suspected heart disease quickly. Delivered under the NHS Long Term Plan, HeartFlow is claimed to convert a regular computed tomography (CT) scan of the heart into a three-dimensional (3D) image to enable the detection of coronary heart disease in 20 minutes, further driving the market growth.
• Due to the surging development of modern visualization methods and technology platforms, along with rising demand for 3D imaging in diagnosing and monitoring chronic diseases, the market is growing. A shift toward minimally invasive procedures and increasing adoption of hybrid operating rooms also provide traction for the market.
• Furthermore, in December 2021, WEHI (Walter and Eliza Hall Institute of Medical Research) researchers developed enhanced 3D imaging technology to model how breast cancer cells invade and spread into the bone and remodify themselves to fuel tumor growth. The research could guide the development of new therapies for patients suffering from cancers that are typically applied to the bone, including breast and prostate cancers.
• The rapid advancements in innovative imagining techniques are paving the way for the growth of the studied market. For instance, in February 2021, a research team led by UMass Lowell introduced a new 3D imaging technique to detect breast cancer and other diseases, including COVID-19. The noninvasive medical technology employs specialized contrasting dye that identifies breast cancer cells, allowing practitioners to visualize human tissue inside the body better. The dye amplifies the X-ray signal in tumors when combined with computed tomography (CT) scanner, called a "photon-counting spectral CT," which produces multi-colored, 3D images. The researchers claimed that the contrast agents, combined with spectral CT and machine learning, could lead to a more precise disease diagnosis and significantly assist in early intervention.
• Furthermore, the COVID-19 pandemic contributed to a 16% increase in the estimated number of deaths in OECD nations in 2020 and the first half of 2021, both directly and indirectly. Life expectancy has decreased in 24 of the 30 countries, and the pandemic has had a significant mental health impact. In addition, the pandemic has resulted in a substantial surge in healthcare spending across the OECD.​

Key Market Trends

Cloud Expected to Witness Significant Growth

• Cloud computing gives medical imaging a competitive advantage in raw data management. Depending on the medical imaging solution types and the industry's development level, cloud computing can be utilized in a variety of scenarios, including cloud image archiving, massive image data storage, and remote medical image disaster recovery, as well as cloud image-based software applications such as 3D healthcare image applications, mobile image reading, and imaging centers.
• The trend for enterprise imaging systems and Picture Archive and Communication systems (PACS) is moving to cloud-based solutions owing to their ability to solve several hospital issues. In addition, cloud-based systems support easier integration with large hospital electronic medical record (EMR) systems.
• Furthermore, hospitals and other healthcare facilities can minimize their IT infrastructure investment by utilizing cloud-based solutions. That means reducing labor costs through automating several repetitive management tasks. Therefore, the cloud is bringing a lot of scalabilities, and physicians can emphasize patients rather than IT concerns.
• Further, in August 2021, GE Healthcare introduced a next-generation, cloud-based Picture Archive and Communication System (PACS) called Edison True PACS. This new cloud-based diagnostic imaging and workflow solution is designed to support and enable radiologists facing increased rates of staff burnout and retirements to be more precise and efficient while keeping capital and IT resources under control. Moreover, this new solution offered AI-enabled decision support to help radiologists acclimate to higher workloads, augment exam complexity, and enhance diagnostic accuracy.

North America Expected to Hold Significant Share

• North America is expected to hold a significant share of the market due to the rising number of surgeries, increasing prevalence of chronic disease, and the growing adoption of the hybrid operating room by hospitals across the region.
• The region is witnessing an increase in automated 3D imaging scanners, and there is ongoing R&D development for 3D imaging. For instance, in July 2022, SMARTTECH expanded its line of 3D scanner accessories. Adding professional FOBA stands to the SMARTTECH accessory line expands the possibilities for the ergonomic use of SMARTTECH 3D scanners.
• The market across the region is significantly growing due to the increasing purchasing power of the healthcare settings, such as hospitals, long-term care centers, and advanced specialty centers. Moreover, compared to developing regions coupled with a favorable reimbursement scenario, a well-established healthcare infrastructure is anticipated to bode well for regional growth during the forecast period.
• Factors such as the growing adoption of automation in the healthcare sector and escalating demand for 3D imaging in diagnosing and monitoring chronic diseases are expected to provide plenty of opportunities for several healthcare companies to expand across the region.
• Further, in January 2022, Francisco Partners signed an agreement with IBM (US) to develop healthcare data and analytics assets from IBM, including Health Insights, MarketScan, Clinical Development, Social Program Management, Micromedex, and imaging software offerings, which are currently part of the Watson Health business.

Competitive Landscape

The 3D medical and surgical imaging platform market is consolidated owing to a few major players in the market. The market players are focusing on R&D to develop technologically advanced products to reduce the cost and side effects associated with the products. The players in this industry are continually working on improving their product portfolio to gain competitive advantages with mergers and acquisitions, partnerships, and constant innovations.

• June 2022 - Trivitron Healthcare plans to launch made-in-India CT-Scan and MRI in 2022-23. Because of its smart features, low cost, and portability will be used for better diagnosis in both the Indian and international markets. In addition, the company intends to open its second ultrasound manufacturing facility in India at Patalganga Industrial Area in Mumbai.
• November 2021 - Royal Philips, a global player in health technology, announced at the Radiological Society of North America the launch of new AI-enabled innovations in MR imaging. Philips' new MR portfolio of intelligent integrated solutions is intended to speed up MR exams, streamline workflows, optimize diagnostic quality, and help ensure radiology operations' efficiency and sustainability.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

• 4.1 Market Overview
• 4.2 Industry Attractiveness - Porters Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Threat of Substitutes
  • 4.2.5 Intensity of Competitive Rivalry
• 4.3 Industry Value Chain Analysis
• 4.4 Assessment of Impact of COVID-19 on the Market

5 MARKET DYNAMICS

• 5.1 Market Drivers
  • 5.1.1 Rising Demand for 3D Imaging in Diagnosing and Monitoring of Chronic Diseases
  • 5.1.2 Rising Healthcare Expenditures
  • 5.1.3 Development of Modern Visualization Methods and Technology Platforms
• 5.2 Market Challenges
  • 5.2.1 High Initial Costs of Equipment

6 MARKET SEGMENTATION

• 6.1 By Deployment
  • 6.1.1 On-premise
  • 6.1.2 Cloud
• 6.2 By Component
  • 6.2.1 Hardware
  • 6.2.2 Software & Solution
• 6.3 By Application
  • 6.3.1 CT-Scan
  • 6.3.2 MRI
  • 6.3.3 Ultrasound
  • 6.3.4 Neurological Imaging
  • 6.3.5 Spinal Imaging
  • 6.3.6 Other Applications
• 6.4 By Geography
  • 6.4.1 North America
  • 6.4.2 Europe
  • 6.4.3 Asia Pacific
  • 6.4.4 Latin America
  • 6.4.5 Middle East & Africa

7 COMPETITIVE LANDSCAPE

• 7.1 Company Profiles
  • 7.1.1 Ambra Health Inc.
  • 7.1.2 Arterys Inc.
  • 7.1.3 Brainlab AG
  • 7.1.4 Depuy Synthes Inc.
  • 7.1.5 Medtronic Inc.
  • 7.1.6 Kitware Inc.
  • 7.1.7 Mach7 Technologies Ltd
  • 7.1.8 NDS Surgical Imaging LLC
  • 7.1.9 Olympus Corporation
  • 7.1.10 NerveVision Inc.
  • 7.1.11 Siemens Healthcare Pvt. Ltd
  • 7.1.12 Pie Medical Imaging BV
  • 7.1.13 Quibim SI

8 INVESTMENT ANALYSIS

9 FUTURE OF THE MARKET